PDS Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	21.66	26.71	41.69	56.56	73.82	65.24
Cash & Short-Term Investments	21.66	26.71	41.69	56.56	73.82	65.24
Cash Growth	-45.82%	-35.93%	-26.29%	-23.38%	13.15%	126.23%
Other Current Assets	1.23	1.54	3.36	2.49	2.66	1.6
Total Current Assets	22.89	28.25	45.05	59.06	76.48	66.84
Net Property, Plant & Equipment	0.23	0.24	0.3	0.34	0.53	0.36
Other Long-Term Assets	1.55	2	-	-	-	-
Total Assets	24.66	30.49	45.36	59.39	77.01	67.2
Accounts Payable	3.65	3.57	1.68	6.98	1.22	1.31
Accrued Expenses	1.26	0.74	2.84	2.42	8.31	2.19
Short-Term Debt	5.21	5.13	12.5	4.17	-	-
Current Portion of Leases	0.03	0.04	0.06	0.06	0.29	0.26
Total Current Liabilities	10.15	9.48	17.09	13.63	9.82	3.76
Long-Term Debt	10.61	11.73	9.2	19.51	23.02	-
Long-Term Leases	0.02	0.03	0.06	0.12	0.16	0.23
Total Long-Term Liabilities	10.62	11.76	9.27	19.63	23.18	0.23
Total Liabilities	20.77	21.24	26.35	33.26	33.01	3.99
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-in Capital	227.83	225.84	201.1	170.62	145.55	123.91
Retained Earnings	-223.96	-216.61	-182.11	-144.5	-101.56	-60.7
Shareholders' Equity	3.89	9.25	19	26.13	44	63.21
Total Liabilities & Equity	24.66	30.49	45.36	59.39	77.01	67.2
Total Debt	15.86	16.93	21.83	23.85	23.47	0.49
Net Cash (Debt)	5.8	9.79	19.86	32.71	50.35	64.75
Net Cash Growth	-40.74%	-50.73%	-39.28%	-35.03%	-22.25%	129.38%
Net Cash Per Share	0.12	0.21	0.55	1.06	1.76	2.53
Book Value	3.89	9.25	19	26.13	44	63.21
Book Value Per Share	0.08	0.20	0.52	0.84	1.54	2.47
Tangible Book Value	3.89	9.25	19	26.13	44	63.21
Tangible Book Value Per Share	0.08	0.20	0.52	0.84	1.54	2.47

SEC Filings: 10-K · 10-Q